Bankers expect bond for DOC Generici buyout

ICG’s purchase of Italian generic pharmaceuticals firm DOC Generici is likely to be financed with high yield bonds, according to bankers, once the deal receives regulatory approval. The deal is said to be worth around €1.2bn in total, though ICG has declined to comment at all on the financing structure.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: